Back
Acumen Pharmaceuticals Stock Price Chart
Sponsored
ABOS
Sponsored
Will Crypto Make People Rich Again Starting April 2024?
Details on how to profit here.
Buy
54
ABOS
Acumen Pharmaceuticals
Last Price:
3.37
Seasonality Move:
65.41%
7 Day Trial
ALL ACCESS PASS
$
7
He cracked the code to crypto
Now he says a new two-year bull market has begun. And he likes one altcoin above all others.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABOS is experiencing slight buying pressure.
Acumen Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.32 | Buy |
20-day SMA: | 3.4 | Buy |
50-day SMA: | 3.84 | Sell |
200-day SMA: | 4.08 | Sell |
8-day EMA: | 3.39 | Buy |
20-day EMA: | 3.44 | Buy |
50-day EMA: | 3.59 | Sell |
200-day EMA: | 4 | Sell |
Acumen Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.11 | Sell |
Relative Strength Index (14 RSI): | 53.54 | Buy |
Chaikin Money Flow: | 37852 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.2 - 3.78) | Buy |
Bollinger Bands (100): | (3.17 - 4.11) | Sell |
Acumen Pharmaceuticals Technical Analysis
Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | May | |||||||||
23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Acumen Pharmaceuticals Stock
Is Acumen Pharmaceuticals Stock a Buy?
- Acumen Pharmaceuticals share price is 3.58 while ABOS 8-day simple moving average is 3.32, which is a Buy signal.
- The stock price of ABOS is 3.58 while Acumen Pharmaceuticals 20-day SMA is 3.40, which makes it a Buy.
- Acumen Pharmaceuticals 50-day simple moving average is 3.84 while ABOS share price is 3.58, making it a Sell technically.
- ABOS stock price is 3.58 and Acumen Pharmaceuticals 200-day simple moving average is 4.08, creating a Sell signal.
ABOS Technical Analysis vs Fundamental Analysis
Buy
54
Acumen Pharmaceuticals (ABOS)
is a Buy
Is Acumen Pharmaceuticals a Buy or a Sell?
-
Acumen Pharmaceuticals stock is rated a Buy
The current Acumen Pharmaceuticals [ABOS] share price is $3.58. The Score for ABOS is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
Acumen Pharmaceuticals Stock Info
Market Cap:
215.09M
Price in USD:
3.58
Share Volume:
170.33K
Acumen Pharmaceuticals 52-Week Range
52-Week High:
11.31
52-Week Low:
1.81
Buy
54
Acumen Pharmaceuticals (ABOS)
is a Buy
Acumen Pharmaceuticals Share Price Forecast
-
What is the Acumen Pharmaceuticals stock price today?
The Acumen Pharmaceuticals stock price is 3.58 USD today. -
Will ABOS stock go up or go down?
Acumen Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Acumen Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Acumen Pharmaceuticals is not overvalued.
Is Acumen Pharmaceuticals Stock a Buy?
- Acumen Pharmaceuticals share price is 3.58 while ABOS 8-day exponential moving average is 3.39, which is a Buy signal.
- The stock price of ABOS is 3.58 while Acumen Pharmaceuticals 20-day EMA is 3.44, which makes it a Buy.
- Acumen Pharmaceuticals 50-day exponential moving average is 3.59 while ABOS share price is 3.58, making it a Sell technically.
- ABOS stock price is 3.58 and Acumen Pharmaceuticals 200-day simple moving average is 4.00, creating a Sell signal.
Fundamental Analysis of Acumen Pharmaceuticals
Is Acumen Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.22 per share, a decrease this year of $0.08 per share, and a decrease next year of $0.15 per share.
Technical Analysis of Acumen Pharmaceuticals
Should I short Acumen Pharmaceuticals stock?
- ABOS Moving Average Covergence Divergence (MACD) indicator is -0.11, suggesting Acumen Pharmaceuticals is a Sell
- Acumen Pharmaceuticals Relative Strength Index (RSI) is 53.54, which suggest Acumen Pharmaceuticals is overbought
- The Bollinger Bands (25) for Acumen Pharmaceuticals is (3.2 - 3.78), which suggest Acumen Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Acumen Pharmaceuticals is (3.17 - 4.11), which suggest Acumen Pharmaceuticals is a Sell
* Acumen Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.